Pearl Bio
Advanced Materials · Biomedical Engineering
$4.1Mlatest round · Venture round · Aug 2021 · 5 yr ago
1backers · Khosla Ventures
$2.5Mgrants · 4 grants · CORDIS
10+team · employees, estimated range
Overview
Pearl Bio’s manufacturing platform unites the precision of biology with the vast diversity of chemistry to create template-directed biomaterials with tunable properties.
Funding and backers
Total raised
$4.1M
5 rounds on record
Latest round
$4.1M
Venture round · Aug 2021 · 5 yr ago
Team
11-50
employees, estimated range
Grants
$2.5M
4 grants · CORDIS
Backers
1
Khosla Ventures
The money's age
Long since its last round
62 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 1, 2024
Won a grant $295k · CORDIS
May 23, 2024
Won a grant $1.7M · CORDIS
Mar 1, 2024
Won a grant $275k · CORDIS
Aug 1, 2023
Won a grant $274k · CORDIS
Aug 31, 2021
Raised a round Venture round $4.1M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Jun 2024 | $295k | — | CORDIS |
| Grant | May 2024 | $1.7M | — | CORDIS |
| Grant | Mar 2024 | $275k | — | CORDIS |
| Grant | Aug 2023 | $274k | — | CORDIS |
| Venture round | Aug 2021 | $4.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Pearl Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Merton GollaherExecutive OfficerSEC Form D
Farren IsaacsExecutive Officer, DirectorSEC Form D
Michael JewettExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
MYCOTEX® is a Biomaterial Technology Company. We engineer next-generation biomaterials for real world products.
A climate technology company reducing global plastic dependency by scaling biomaterial adoption.
Discover UNCAGED Innovations. We engineer premium, sustainable biomaterials and cruelty-free leather alternatives for global brands.
TômTex is a materials innovation company that is creating a new class of next-gen biomaterials.
We transform 100% traceable seaweed into innovative biomaterials—brilliantly designed for beauty, food and beyond.
Sustanix develops novel biomolecules for advanced biomaterials, takes it from lab to industrial scale.
People
Merton Gollaher
Executive Officer
Farren Isaacs
Executive Officer, Director
Michael Jewett
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Khosla VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Report
Michael Jewett, PhD
Dr. Michael Jewett is the Professor in Bioengineering at Stanford University. Dr. Jewett received his PhD in 2005 at Stanford University, completed postdoctoral studies at the Center for Microbial Biotechnology in Denmark and the Harvard Medical School, a
Read more
Report
Farren Isaacs, PhD
Dr. Farren Isaacs is an Associate Professor of Molecular, Cellular, and Developmental Biology and Biomedical Engineering at Yale University. Dr. Isaacs has pioneered technologies for genome and RNA engineering for the construction of organisms with recode
Read more
Report
Amy Cayne Schwartz, JD
Amy Cayne Schwartz is spearheading operations, business strategy and is the General Counsel for Pearl Bio. Ms. Schwartz is also the President and General Counsel of Genome Project-write (GP-write), a non-profit global consortium, where she oversees the te
Read more
Report
Jesse Rinehart, PhD
Dr. Jesse Rinehart is an Associate Professor in the Department of Cellular & Molecular Physiology at the Yale University School of Medicine with a joint appointment in the Yale Systems Biology Institute. Dr. Rinehart has led groundbreaking research in gen
Read more
Report
George Church, PhD
Dr. George Church is professor of genetics at Harvard Medical School, a founding member of the Wyss Institute, and director of PersonalGenomes.org, the world's only open-access information on human genomic, environmental, and trait data. Church is known f
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United States
HQ
Address
10-50 est. staff
Pearl Bio, Inc. | 700 Main St | Cambridge MA 02139